ВТОРИЧНЫЙ ГИПЕРПАРАТИРЕОЗ: ПАТОГЕНЕЗ И КЛИНИЧЕСКИЕ АСПЕКТЫ
Ключевые слова:
Гиперпаратиреоз, первичный, вторичный, третичный, паратиреоидный гормон, кальций, фосфор, витамин ДАннотация
В обзоре представлены данные о гиперпаратиреозе первичном, вторичном, третичном, их причинах, клиническом течении и диагностике. Паратиреоидный гормон и механизм его действия были подробно описаны с иллюстрациями. Авторы описали причины, приводящие к первичному, вторичному и третичному гиперпаратиреозу, представили дифференциацию симптомов и признаков в таблицах и схемах. Обзор включает литературные данные о принципах медикаментозного и хирургического лечения гиперпаратиреоза, классах препаратов и сравнении их механизма действия, показаниях к операции и предоперационном лечении и наблюдении. Этот обзор представляет интерес для семейных врачей, врачей- специалистов, таких как эндокринологи, нефрологи, врачи гемодиализа, хирургов, а также для студентов, магистров и ординаторов.
Библиографические ссылки
Bleyer AJ, Burke SK, Dillon M, Garrett B, Kant KS, Lynch D, Rahman SN, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E: A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis 33: 694–701, 1999
Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350:1516–1525.
Brown AJ, Dusso AS, Slatopolsky E: Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant 17: 10–19, 2002
Chang CY, Rosenthal DI, Mitchell DM, Handa A, Kattapuram SV, Huang AJ. Imaging Findings of Metabolic Bone Disease. Radiographics. 2016 Oct;36(6):1871-1887. [PubMed]
Chen H, Wang TS, Yen TW, Doffek K, Krzywda E, Schaefer S, Sippel RS, Wilson SD. Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Ann Surg. 2010 Oct;252(4):691-5.
Chiu B , Sturgeon C , Angelos P . Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg 2006;141:483– 8.
Colloton M, Shatzen E, Miller G, Stehman-Breen C, Wada M, Lacey D, Martin D: Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 67: 467–476, 2005
Cozzolino M, Tomlinson J, Walsh L, Bellasi A. Emerging drugs for secondary hyperparathyroidism. Expert Opin Emerg Drugs. 2015;20(2):197–208.
Di Stasio E , Carrozza C , Pio Lombardi C , Raffaelli M , Traini E , Bellantone R , Zuppi C . Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end- point. Clin Biochem 2007;40:595–603.
El-Kishawi AM, El-Nahas AM. Renal osteodystrophy: review of the disease and its treatment. Saudi J Kidney Dis Transpl. 2006 Sep;17(3):373-82. [PubMed]
Galassi A, Cupisti A, Santoro A, Cozzolino M. Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool. J Nephrol. 2015;28:415–429.
Galitzer H, Lavi-Moshayoff V, Nechama M, Meir T, Silver J, Naveh-Many T: The calcium- sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells. BMC Biol 7: 17, 2009
Gough I. Reoperative parathyroid surgery: the importance of ectopic location and multigland disease. ANZ J Surg. 2006 Dec;76(12):1048-50.
Goyal A, Anastasopoulou C, Ngu M, Singh S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 8, 2021. Hypocalcemia.
Guidelines by the Japanese Society for Dialysis Therapy 2017
Hans SK, Levine SN. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 18, 2021. Hypoparathyroidism
Irvin GL , Deriso GT . A new, practical intraoperative parathyroid hormone assay. Am J Surg 1994;168:466–8.
Illustrated Anatomy of the Head and Neck, Fehrenbach and Herring, Elsevier, 2012, p. 159
JANCAR J. RICKETS WITH SECONDARY HYPERPARATHYROIDISM IN A SEVERELY SUBNORMAL CHILD. Arch Dis Child. 1963 Aug;38(200):412-4. [PMC free article] [PubMed]
Joliat GR, Guarnero V, Demartines N, Schweizer V, Matter M. Recurrent laryngeal nerve injury after thyroid and parathyroid surgery: Incidence and postoperative evolution assessment. Medicine (Baltimore). 2017 Apr;96(17):e6674.
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1–S130.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. [PMC free article] [PubMed]
Komaba H, Nakanishi S, Fujimori A, Tanaka M, Shin J, Shibuya K, Nishioka M, Hasegawa H, Kurosawa T, Fukagawa M: Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol 5: 2305–2314, 2010
Lacativa PG, Franco FM, Pimentel JR, Patrício Filho PJ, Gonçalves MD, Farias ML. Prevalence of radiological findings among cases of severe secondary hyperparathyroidism. Sao Paulo Med J. 2009 May;127(2):71-7. [PubMed]
Lappas D, Noussios G, Anagnostis P, Adamidou F, Chatzigeorgiou A, Skandalakis P (September 2012). "Location, number and morphology of parathyroid glands: results from a large anatomical series". Anat Sci Int. 87 (3): 160–4. doi:10.1007/s12565-012-0142-1. PMID 22689148. S2CID 207431255
Lau, WL; Obi, Y; Kalantar-Zadeh, K (7 June 2018). "Parathyroidectomy in the Management of Secondary Hyperparathyroidism". Clinical Journal of the American Society of Nephrology. 13 (6): 952–961. doi:10.2215/CJN.10390917
Llach F, Fernández E. Overview of renal bone disease: causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach. Kidney Int Suppl. 2003 Nov;(87):S113-9. [PubMed]
Mazotas IG, Yen TWF, Doffek K, Shaker JL, Carr AA, Evans DB, Wang TS. Persistent/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role? J Surg Res. 2020 Feb;246:335-341
Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM: Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20: 2186– 2193, 2005
Oprisiu R, Hottelart C, Ghitsu S, Said S, Westeel PF, Morinière P, el Esper N, Pruna A, Fournier A. [Renal osteodystrophy (1): invasive and non-invasive diagnosis of its pathologic varieties]. Nephrologie. 2000;21(5):229-37. [PubMed]
Patel SR, Ke HQ, Vanholder R, Koenig RJ, Hsu CH: Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 96: 50–59, 199
Parathyroid surgery: Recovery, The American Association of Endocrine Surgeons
Robbins and Cotran pathologic basis of disease. Kumar, Vinay, 1944-, Abbas, Abul K.,, Aster, Jon C.,, Perkins, James A. (Ninth ed.). Philadelphia, PA. 2014.
Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Ho LY, Wong PN, Sin HK, Wong YY, Lo KC, Chan SF, Lo MW, Lo KY, Mak SK, Wong AKBMC Nephrol. 2017 Jan 10; 18(1):12.
Rosenbaum MA, Haridas M, McHenry CR. Life-threatening neck hematoma complicating thyroid and parathyroid surgery. Am J Surg. 2008 Mar;195(3):339-43; discussion 343.
Sekercioglu N, Angeliki Veroniki A, Thabane L, et al. Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: a systematic review and NMA. PLoS One. 2017;12(3):e0171028.
Slatopolsky E, Brown A, Dusso A: Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl 73: S14–S19, 1999
Schlosser K, Veit JA, Witte S, et al. Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT- Trial. Trials 2007;8:22
The Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines 2007
Wilkieson TJ, Rahman MO, Gangji AS, Voss M, Ingram AJ, Ranganath N, Goldsmith CH, Kotsamanes CZ, Crowther MA, Rabbat CG, Clase CM. Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on hemodialysis. Can J Kidney Health Dis. 2015;2:29. [PMC free article] [PubMed]
